Coverage
-
July 12, 2016
A Delaware federal judge ruled Monday that Mylan Inc.'s attempt to make a generic version of fibromyalgia treatment Savella infringed three patents held by Forest Laboratories Holdings Ltd. and that the patents' asserted claims are valid.
2 other articles on this case.
View all »